Author

Jane M Heffernan

Centre for Disease Modelling, Mathematics & Statistics, York University - Cited by 5,083

Biography

Dr Heffernan is an Associate Professor in the Department of Mathematics and Statistics at York University, and York Research Chair (Tier II). She is also the Director of the Centre for Disease Modelling (CDM), and is on the Board of Directors of the Society of Mathematical Biology (SMB).Dr Heffernans research program centres on understanding the spread and persistence of infectious diseases. Her, Modelling Infection and Immunity Lab (MI2), which is affiliated with the Centre for Disease Modelling (CDM) focuses on the development of new biologically motivated models of infectious diseases (deterministic and stochastic).
Title
Cited by
Year
Integrated vaccination and non-pharmaceutical interventions based strategies in Ontario, Canada, as a case study: a mathematical modelling study
M Betti, NL Bragazzi, JM Heffernan, J Kong, A RaadJournal of The Royal Society Interface 18 (180), 20210009, 2021202
23
2021
Modeling waning and boosting of COVID-19 in Canada with vaccination
L Childs, DW Dick, Z Feng, JM Heffernan, J Li, G RöstEpidemics 39, 100583, 202
22
2022
Efficacy of a “stay-at-home” policy on SARS-CoV-2 transmission in Toronto, Canada: a mathematical modelling study
P Yuan, J Li, E Aruffo, E Gatov, Q Li, T Zheng, NH Ogden, B Sander, ...Canadian Medical Association Open Access Journal 10 (2), E367-E378, 2022202
18
2022
Commentary on the use of the reproduction number R during the COVID-19 pandemic
C Vegvari, S Abbott, F Ball, E Brooks-Pollock, R Challen, BS Collyer, ...Statistical Methods in Medical Research 31 (9), 1675-1685, 2022202
17
2022
Analysis of host immunological response of adenovirus-based COVID-19 vaccines
S Farhang-Sardroodi, CS Korosec, S Gholami, M Craig, IR Moyles, ...Vaccines 9 (8), 861, 2021202
15
2021
Assessing transmission risks and control strategy for monkeypox as an emerging zoonosis in a metropolitan area
P Yuan, Y Tan, L Yang, E Aruffo, NH Ogden, J Belair, J Heffernan, J Arino, ...Journal of Medical Virology 95 (1), e28137, 2023202
15
2023
Longitudinal assessment of SARS-CoV-2-specific T cell cytokine-producing responses for 1 year reveals persistence of multicytokine proliferative responses, with greater …
J Lin, R Law, CS Korosec, C Zhou, WH Koh, MS Ghaemi, P Samaan, ...Journal of Virology 96 (13), e00509-22, 2022202
14
2022
Could a new covid-19 mutant strain undermine vaccination efforts? a mathematical modelling approach for estimating the spread of b. 1.1. 7 using ontario, canada, as a case study
M Betti, N Bragazzi, J Heffernan, J Kong, A RaadVaccines 9 (6), 592, 2021202
13
2021
Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex
CS Korosec, S Farhang-Sardroodi, DW Dick, S Gholami, MS Ghaemi, ...Scientific reports 12 (1), 21232, 2022202
11
2022
Modelling COVID-19 transmission in a hemodialysis centre using simulation generated contacts matrices
M Tofighi, A Asgary, AA Merchant, MA Shafiee, MM Najafabadi, N Nadri, ...PLoS One 16 (11), e0259970, 2021202
10
2021
A threshold policy to curb WNV transmission to birds with seasonality
W Zhou, Y Xiao, JM HeffernanNonlinear Analysis: Real World Applications 59, 10323, 2021202
7
2021
COVID-19 seroprevalence in Canada modelling waning and boosting COVID-19 immunity in Canada a Canadian immunization research network study
DW Dick, L Childs, Z Feng, J Li, G Röst, DL Buckeridge, NH Ogden, ...Vaccines 10 (1), 1, 2021202
7
2021
Modeling vaccination and control strategies for outbreaks of monkeypox at gatherings
P Yuan, Y Tan, L Yang, E Aruffo, NH Ogden, J Belair, J Arino, J Heffernan, ...Frontiers in Public Health 10, 1026489, 2022202
7
2022
In elimination settings, measles antibodies wane after vaccination but not after infection: a systematic review and meta-analysis
S Bolotin, S Osman, SL Hughes, A Ariyarajah, AC Tricco, S Khan, L Li, ...The Journal of infectious diseases 22 (7), 1127-1139, 2022202
6
2022
Long-term predictions of humoral immunity after two doses of BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex
CS Korosec, S Farhang-Sardroodi, DW Dick, S Gholami, MS Ghaemi, ...MedRxiv, 2021.10. 13.2126497, 2021202
5
2021
Determination of significant immunological timescales from mRNA-LNP-based vaccines in humans
IR Moyles, CS Korosec, JM HeffernanJournal of Mathematical Biology 86 (), 86, 2023202
5
2023
A machine learning approach to differentiate between COVID-19 and influenza infection using synthetic infection and immune response data
S Farhang-Sardroodi, MS Ghaemi, M Craig, HK Ooi, JM HeffernanmedRxiv, 2022.01. 27.22269978, 2022202
4
2022
Estimating the basic reproduction number at the beginning of an outbreak
S Boonpatcharanon, JM Heffernan, H JankowskiPlos one 17 (6), e026906, 2022202
3
2022
Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: Parameter estimates, identifiability, sensitivity and the eclipse phase profile
CS Korosec, MI Betti, DW Dick, HK Ooi, IR Moyles, LM Wahl, ...Journal of theoretical biology 564, 111449, 20220
3
2023
A pair formation model with recovery: Application to monkeypox
M Betti, L Farrell, JM HeffernanmedRxiv, 2022.08. 17.22278897, 2022202
3
2022

Referred From: https://scholar.google.com/citations?hl=en&user=st35hykAAAAJ

Cited by
Citations 5083
h-index 29
i10-index 65
Recommended Journals
Open Access Journals